Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Long-term results of thumb carpometacarpal joint arthrodesis.

Archives of orthopaedic and trauma surgery·2026

Same author

Factors associated with variation in treatment of the distal radioulnar joint after plate fixation of distal radial fractures.

The Journal of hand surgery, European volume·2026

Same author

Identification of novel CLK1 inhibitors by computational fragment-based ligand design, co-crystallization, chemical synthesis and structure activity relationships.

European journal of medicinal chemistry·2026

Same author

Restoration of CPAK type in total knee arthroplasty does not lead to superior clinical outcome: A study based on arthroplasty registry data.

Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA·2026

Same author

Combined trochleoplasty and medial patellofemoral ligament reconstruction reduces patellar height.

Journal of experimental orthopaedics·2026

Same author

No significant side-to-side differences in retropatellar load distribution using more than 7.5 years after isolated MPFL reconstruction: A CT-osteoabsorptiometry pilot study in nine patients.

Journal of experimental orthopaedics·2026

Search research articles

Related Experiment Video

Updated: Mar 23, 2026

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

Advanced molecular dynamics simulation methods for kinase drug discovery.

Samia Aci-Sèche¹, Sonia Ziada¹, Abdennour Braka¹

¹Institut de Chimie Organique et Analytique (ICOA), UMR CNRS-Université d'Orléans 7311, Université d'Orléans BP 6759, 45067 Orléans Cedex 2, France.

Future Medicinal Chemistry

|April 8, 2016

Summary

Molecular dynamics (MD) simulations are increasingly used for protein kinase (PK) drug discovery. This review covers MD methods and their applications in understanding PKs and finding new inhibitors for diseases like cancer.

Keywords:

conformational sampling drug discovery molecular dynamics simulation protein kinase protein–ligand association process structure–kinetics relationship

More Related Videos

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

Related Experiment Videos

Last Updated: Mar 23, 2026

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

Area of Science:

Biochemistry
Computational Biology
Pharmacology

Background:

Protein kinases (PKs) are crucial drug targets, particularly in oncology, due to their role in disease pathogenesis.
Molecular dynamics (MD) simulations offer atomic-level insights into the dynamic behavior of biological and chemical systems.
Integrating MD with other computational and experimental techniques enhances drug discovery efficiency.

Purpose of the Study:

To review common and advanced molecular dynamics (MD) simulation methodologies.
To highlight recent applications of MD in understanding protein kinase (PK) biological mechanisms.
To showcase MD's contribution to the discovery of novel kinase inhibitors.

Main Methods:

Review of established and cutting-edge MD simulation techniques.
Analysis of case studies demonstrating MD's utility in PK research.
Integration of MD simulation data with experimental findings.

Main Results:

MD simulations provide detailed insights into PK function and inhibition.
MD-based approaches have accelerated the identification of potential drug candidates.
The review consolidates current knowledge on MD applications in PK drug discovery.

Conclusions:

Molecular dynamics simulations are a powerful tool in modern protein kinase drug discovery.
MD methodologies offer significant advantages for elucidating complex biological mechanisms.
Continued application of MD is expected to drive innovation in kinase inhibitor development.